NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding NRX Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 30 | 32 | +2 |
| Shares | 3.15M | 9.89M | +6.75M (+214.3%) |
| Value | $2.07M | $4.78M | +$2.71M (+130.6%) |
New holders (6)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 5,636,000 | $2.73M | 0.07% |
| Sabby Management, LLC | 699,731 | $338.3K | 1.21% |
| CVI Holdings, LLC | 483,569 | $233.8K | 0.25% |
| Jane Street Group, LLC | 15,052 | $7.28K | 0.00% |
| Ieq Capital, LLC | 10,000 | $4.83K | 0.00% |
| Impact Partnership Wealth, LLC | 940 | $454 | 0.00% |
Sold out (4)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 80,623 | $53.1K |
| Virtu Financial LLC | 46,210 | $30.0K |
| Column Capital Advisors, LLC | 100 | $66 |
| VitalStone Financial, LLC | 10 | $0 |